NYT Declined Zyprexa Court Invitation_Secrecy’s Dangerous SideEffects
"When legal settlements allow companies to hide their mistakes, what we don't know can hurt us."
-
-
SEC Filings: Eli Lilly Admits Problems Getting Liability Insurance For Zyprexa
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.
-
Lilly -Zyprexa Casualties-$1.2 Billion Settlements-More Casualties_NYT_WSJ
Eli Lilly's latest Zyprexa settlement will not affect civil or criminal investigations pending over Zyprexa from state attorneys general and federal prosecutors, which are continuing.
-
Zyprexa Sales Rep on YouTube: A Video You Must See
Spread the word! See and pass along: "Zyprexa Sales Rep" posted on YouTube:
http://www.youtube.com/watch?v=nj0LZZzrcrs
-
Houston TX – Drug Makers Accused Of Misleading Health Dept_ KEYE-TV
The Texas whistleblower lawsuit against Johnson & Johnson promises to topple the house of cards upon which the public mental health system rests.
-
Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings
The question is: will Eli Lilly succeed, once again, to divert public attention from the revelations contained in its internal documents about the company's illegal marketing practices and its failure to warn about lethal risks posed by its product?
-
Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label Use
State Attorney Generals are investigating the off-label marketing of Zyprexa–which, if documented is a federal crime.
-
Documents Show Eli Lilly Lied about Zyprexa
The New York Times is calling for congressional hearings after the revelations that Eli LillyDocumented evidence reveal that Eli Lilly glossed over the debilitating hazards of Zyprexa–and aggressively marketed it to primary care physicians.
-
AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
"Most off-label use occurs without scientific support."
-
Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT
The New York Times reports that internal marketing documents show that “Eli Lilly encouraged primary care physicians to use Zyprexa, in patients who did not have either condition.”
-
DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE
THE NEW YORK TIMES EXPOSE OF ELI LILLY SECRET ZYPREXA DOCUMENTS Part II.
-
Eli Lilly Documents Show Risks of Zyprexa were deliberately played down_NYT
NY Times reports: In March 2002, Lilly rejected plans to give psychiatrists guidance about how
to treat diabetes, "worrying that doing so would tarnish Zyprexa's reputation."